Since publication of the WHI in 2002 the use of conventional hormone therapy has dropped about 50-60%. At the same time, the use of custom compounded bio-identical hormone therapy (CBHT) has increased significantly. This session will examine the risks and benefits of CBHT versus FDA-approved BHT (FDA-BHT) and the ways in which these hormones differ from each other and from synthetic hormone therapy. In addition, we will evaluate the effectiveness of saliva testing in determining post-menopausal hormone status. Finally, position statements from 7 professional organizations regarding the use of CBHT will be reviewed.
You must be signed in to access this course. You can sign in at the top right-hand corner of the page.
**If you are an NPWH member, were once a member, or have taken CE activities with NPWH in the past, you have a username and password in our new system. Please DO NOT create a new account. Creation of multiple accounts could result in loss of CE credits as well as other NPWH services. If you do not remember your username or password, please either click on the "forgot username" or "forgot password" links at the bottom of the sign in screen or call the NPWH office at (202) 543-9693 ext. 1.**